Skip to content

TransCelerate Event

The Use of Virtual Controls in Preclinical Research: Promise and Predicament

Join BioCelerate for its second meeting of the BioCelerate Preclinical Collaboration Forum, which brings together cross-industry stakeholders to advance conversation and innovation in preclinical research.

During this forum industry leaders will address the following topics:

  • How virtual controls may play a role in a reduce, reuse, recycle strategy (3R)
  • Considerations to ensure the scientific validity of study designs
  • Likely challenges or barriers to success and potential ways to overcome them

Featured panelists include:

  • Esther Vock, Director of Special Toxicology, (Genetic Toxicology, Immunotoxicology & Data Sciences), Boehringer Ingelheim Pharmaceuticals; Governing Council, BioCelerate
  • Kevin Snyder, Associate Director of Nonclinical Informatics, U.S. Food & Drug Administration
  • Thomas Steger-Hartmann, Head of Investigational Toxicology, Vice President, Bayer AG Pharmaceuticals
  • Lars Mecklenburg, Site Managing Director & Executive Safety Assessment, Labcorp
  • Laura Lotfi, Translational Sciences & Data Analytics Manager, Charles River

Attendees of the BioCelerate Collaboration Forum include representatives from:

  • Sponsors
  • Health Authorities
  • CROs
  • Industry Groups